Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin.
Gratieri T, Alberti I, Lapteva M, Kalia YN. Gratieri T, et al. Among authors: alberti i. Eur J Pharm Sci. 2013 Dec 18;50(5):609-22. doi: 10.1016/j.ejps.2013.03.019. Epub 2013 Apr 6. Eur J Pharm Sci. 2013. PMID: 23567467 Review.
Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.
Alberti I, Grenier A, Kraus H, Carrara DN. Alberti I, et al. Expert Opin Drug Deliv. 2005 Sep;2(5):935-50. doi: 10.1517/17425247.2.5.935. Expert Opin Drug Deliv. 2005. PMID: 16296788 Review.
In vivo methods for the assessment of topical drug bioavailability.
Herkenne C, Alberti I, Naik A, Kalia YN, Mathy FX, Préat V, Guy RH. Herkenne C, et al. Among authors: alberti i. Pharm Res. 2008 Jan;25(1):87-103. doi: 10.1007/s11095-007-9429-7. Epub 2007 Nov 6. Pharm Res. 2008. PMID: 17985216 Free PMC article. Review.
Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery.
Chen Y, Zahui T, Alberti I, Kalia YN. Chen Y, et al. Among authors: alberti i. Eur J Pharm Biopharm. 2016 Feb;99:94-102. doi: 10.1016/j.ejpb.2015.11.010. Epub 2015 Nov 22. Eur J Pharm Biopharm. 2016. PMID: 26592154
Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability.
Chen Y, Alberti I, Kalia YN. Chen Y, et al. Among authors: alberti i. Eur J Pharm Biopharm. 2016 Feb;99:103-13. doi: 10.1016/j.ejpb.2015.12.002. Epub 2015 Dec 11. Eur J Pharm Biopharm. 2016. PMID: 26686649
Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo.
Alberti I, Kalia YN, Naik A, Bonny J, Guy RH. Alberti I, et al. Int J Pharm. 2001 May 21;219(1-2):11-9. doi: 10.1016/s0378-5173(01)00616-0. Int J Pharm. 2001. PMID: 11337162
RESULTS: The concentration profile of TBF in the SC (i.e. drug concentration as a function of depth in the membrane) was fitted to the appropriate solution of Fick's second law of diffusion, allowing thereby the drug's SC/vehicle partition coefficient (K) and characteristi …
RESULTS: The concentration profile of TBF in the SC (i.e. drug concentration as a function of depth in the membrane) was fitted to th …
In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum.
Alberti I, Kalia YN, Naik A, Bonny JD, Guy RH. Alberti I, et al. J Control Release. 2001 Apr 28;71(3):319-27. doi: 10.1016/s0168-3659(01)00244-9. J Control Release. 2001. PMID: 11295224
Erratum to "Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability" [Eur. J. Pharm. Biopharm. 99 (2016) 103-113].
Chen Y, Alberti I, Kalia YN. Chen Y, et al. Among authors: alberti i. Eur J Pharm Biopharm. 2016 May;102:19. doi: 10.1016/j.ejpb.2016.02.011. Epub 2016 Feb 26. Eur J Pharm Biopharm. 2016. PMID: 27038092 No abstract available.
Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness.
Kalia YN, Alberti I, Naik A, Guy RH. Kalia YN, et al. Among authors: alberti i. Skin Pharmacol Appl Skin Physiol. 2001;14 Suppl 1:82-6. doi: 10.1159/000056394. Skin Pharmacol Appl Skin Physiol. 2001. PMID: 11509911 Review.
Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo, in man.
Alberti I, Kalia YN, Naik A, Guy RH. Alberti I, et al. Pharm Res. 2001 Oct;18(10):1472-5. doi: 10.1023/a:1012217209228. Pharm Res. 2001. PMID: 11697475 No abstract available.
36 results
Jump to page
Feedback